| Financial Instruments - Additional Information (Details) - USD ($) $ in Thousands | Jun. 30, 2022 | Dec. 31, 2021 | Dec. 08, 2021 | 
|---|---|---|---|
| Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | |||
| Marketable equity securities | $ 23,864 | ||
| Gross unrealized gains | 3,859 | ||
| Contingent consideration, liability (up to) | 2,824 | ||
| Investments in privately held entities | $ 13,300 | $ 5,000 | |
| Company X | Contingent Consideration - Company X | |||
| Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | |||
| Contingent consideration, liability (up to) | $ 3,000 | 
| X | ||||||||||
| 
- Definition Equity Securities, Accumulated Net Unrealized Gain No definition available. 
 | 
| X | ||||||||||
| 
- Definition Amount of liability recognized arising from contingent consideration in a business combination. Reference 1: http://www.xbrl.org/2003/role/disclosureRef 
 | 
| X | ||||||||||
| 
- Definition Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI). Reference 1: http://www.xbrl.org/2003/role/disclosureRef 
 | 
| X | ||||||||||
| 
- Definition Amount of investment in equity security without readily determinable fair value. Reference 1: http://www.xbrl.org/2003/role/disclosureRef 
 | 
| X | ||||||||||
| 
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available. 
 | 
| X | ||||||||||
| 
- Details 
 | 
| X | ||||||||||
| 
- Details 
 |